Communiqués BenevolentAI S.A.

Actions

BAI

LU2355630455

Recherche biotechnologique et médicale

Marché Fermé - Euronext Amsterdam Autres places de cotation 17:38:47 12/03/2025			Varia. 5j.	Varia. 1 janv.
0,0810 ^EUR	-14,74 %		-.--%	-

12/03	BenevolentAI Limited annonce la nomination de Kenneth Patrick Mulvany en tant qu'administrateur, à compter du 10 mars 2026	CI
02/10/25	BenevolentAI S.A. publie ses résultats annuels pour l'exercice clos le 31 décembre 2024	CI

Communiqués

13/03/25	BenevolentAI : Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam	PU
12/03/25	BenevolentAI : EGM Results announcement	PU
12/03/25	Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam	BU
12/03/25	BenevolentAI : Inside Information / Ad Hoc Information - BENEVOLENTAI S.A.	PU
10/02/25	BenevolentAI : General Meeting - BENEVOLENTAI S.A.	PU
06/02/25	BenevolentAI : Inside Information / Ad Hoc Information - BENEVOLENTAI S.A.	PU
06/02/25	Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting	BU
11/12/24	BenevolentAI : Benevolent AI, - BenevolentAI unveils major strategic overhaul with return to original mission	PU
11/12/24	BenevolentAI : Inside Information / Ad Hoc Information - BENEVOLENTAI S.A.	PU
11/12/24	BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission	BU
17/10/24	BenevolentAI : Benevolent AI, - BenevolentAI Appoints Kenneth Mulvany as Executive Chairman	PU
17/10/24	BenevolentAI : Inside Information / Ad Hoc Information - BENEVOLENTAI S.A.	PU
17/10/24	BenevolentAI Appoints Kenneth Mulvany as Executive Chairman	BU
10/10/24	BenevolentAI to Present on Explainable AI for Drug Discovery at BioTechX Europe 2024	BU
19/09/24	BenevolentAI : Benevolent AI, - BenevolentAI 0 Interim results for the six months ended 30 June 2024	PU
19/09/24	BenevolentAI : Half yearly fcial & audit reports / ltd reviews - BENEVOLENTAI S.A.	PU
19/09/24	BenevolentAI Interim Results for the Six Months Ended 30 June 2024	BU
09/09/24	BenevolentAI Notice of Interim Results	AQ
06/09/24	BenevolentAI Notice of Interim Results	BU
05/07/24	BenevolentAI - Appointment of Adviser	AQ
04/07/24	BenevolentAI: Appointment of Adviser	BU
03/07/24	BenevolentAI : Benevolent AI, BenevolentAI Leadership Team change	PU
03/07/24	BenevolentAI : Inside Information / Ad Hoc Information BenevolentAI - Leadership Team change	PU
03/07/24	BenevolentAI: Leadership Team Change	BU
25/06/24	BenevolentAI and AstraZeneca Collaboration Yields Continued Success as Further Novel Target Progressed Into Portfolio	BU